SPRI | Cancer Vaccines (2017 EN)

Discussion in 'Medicine' started by Kanka, Jul 15, 2017.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,037
    Likes Received:
    449
    Trophy Points:
    83
    [​IMG]

    Author: Natalia Savelyeva (Editor), Christian Ottensmeier (Editor)
    Full Title: Cancer Vaccines
    Publisher: Springer; 1st ed. 2017 edition (July 11, 2017)
    Year: 2017
    ISBN-13: 9783319239101 (978-3-319-23910-1), 9783319239095 (978-3-319-23909-5)
    ISBN-10: 3319239104, 3319239090
    Pages: 210
    Language: English
    Genre: Biomedical Sciences: Cancer Research
    File type: PDF (True)
    Quality: 10/10
    Price: 161.19 €


    This volume focuses on the laboratory and clinical experience with targeting viral onco-antigens, while also reviewing the approaches to targeting self-cancer antigens in cancers of non-viral origin, where self-tolerance has been a challenge. It emphasizes the importance of selecting the right vaccine platform to induce a successful immune response against cancer antigens. In addition, the volume discusses the advances made with genetic vaccines, including recent advances with DNA vaccines and the rapid transition of mRNA vaccines from the laboratory to bedside. The new avenues opening up for cancer immunotherapy underline the importance of combinational approaches using cancer vaccines with costimulatory antibodies, which may dramatically improve cancer treatment.

    This book is intended for all translational researchers and clinicians who aspire to develop novel vaccination approaches for cancer patients with unmet clinical needs.

    -------------
     
    Last edited by a moderator: Nov 27, 2019